<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
<meta name="theme-color" content="#1B2631">
<title>Preoperative Sedation</title>
<link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&display=swap" rel="stylesheet">
<style>
*{margin:0;padding:0;box-sizing:border-box}
body{font-family:'DM Sans',sans-serif;background:#f8fafc;padding-bottom:60px}
.header{background:linear-gradient(135deg,#1B2631 0%,#2C3E6B 100%);padding:14px 16px;color:#fff;
position:sticky;top:0;z-index:10;display:flex;align-items:center;gap:12px}
.header a{color:#94a3b8;text-decoration:none;font-size:22px}
.header h1{font-size:15px;font-weight:700;letter-spacing:-0.02em}
.content{padding:16px;max-width:480px;margin:0 auto}
.tag{display:inline-block;background:#FEF9E7;color:#7D6608;font-size:10px;font-weight:600;
padding:2px 8px;border-radius:10px;margin-bottom:12px}
</style>
</head>
<body>
<div class="header">
<a href="javascript:history.back()">&larr;</a>
<h1>Preoperative Sedation</h1>
</div>
<div class="content">
<span class="tag">NDHT Guideline</span>
<h1 style="font-size:18px;color:#1B2631;margin:0 0 16px;border-bottom:2px solid #E67E22;padding-bottom:8px">Preoperative Sedation Guideline</h1>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">SUMMARY</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">KEY POINTS</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">CONTENTS</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">1.  INTRODUCTION	3</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">2.  BACKGROUND	3</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">3.  DEFINITIONS 	4</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">4.  Sedative Pre Medication	4</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Aims	4</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Indications and Contra Indications	5</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Roles and Responsibilities	5</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Consent	6</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Choice of pre medication	6</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">After administration	8</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 1 Sedative Premedication Dosing in Paediatric Patients	 9</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 2 Sedative Premedication Dosing in Adult Patients 	11</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 3 Summary Flow Chart	12</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 4 Intramuscular Ketamine	15</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 5 Intranasal Dexmedetomidine	16</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">5.  MONITORING COMPLIANCE WITH THIS GUIDELINE	#</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">6.  ASSOCIATED CLINICAL GUIDELINES OR POLICIES/PROCEDURES	#</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">7.  PUBLICATION DETAILS	#</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">1.	INTRODUCTION</h2>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">This clinical guideline is designed to provide advice, guidance and direction to staff whilst leaving room for professional judgement, and adaptation, to fit individual circumstances.</li>
</ul>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">This purpose of this document is to formalise current practice and improve the prescribing and administration of sedative pre- medication when used before general anaesthesia.</li>
</ul>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">2.	BACKGROUND</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Sedation prior to an anaesthetic may be required for many reasons including anxiolysis and to improve the patient’s experience of anaesthesia and surgery.  Groups of children and adults who may particularly benefit include those with special educational or behavioural needs (e.g. Autistic patients, Down’s syndrome, etc), children having major surgery, repeated procedures or those who have had a previous bad experience of the hospital environment.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The advantages of sedation are that it can reduce both patient and carer anxiety therefore improving the overall experience. It can provide amnesia and may reduce behavioural changes post operatively.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The advantages must outweigh possible disadvantages including worsening anxiety associated with administration of the medication, paradoxical reactions that can occasionally be seen (e.g. with benzodiazepines) and the potentiation of sedative side effects of drugs such as opioids.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Sedation is one method of reducing anxiety but non-pharmacological methods should also be considered and may be used in addition to or as well as medications.  Play Specialists and the adult Learning Disability teams are particularly helpful in this regard and a formal referral can be made to them either ahead of admission or on the day of surgery for paediatric and adult patients respectively.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">On the Northern Site these patients will have a ”Reasonable Adjustment Pathway” completed prior to surgery. On the Eastern site a ‘This is me’ passport will be introduced for autistic children and patients with ADHD or chronic illness which will help to describe what particularly triggers anxiety and what helps to reduce distress.  A hospital passport is also available for adults with additional needs on the Eastern side.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">This guideline has been developed to provide clarity on selecting sedative medication and managing children or adults once the sedative medication has been administered.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">These guidelines are intended for patients requiring pre-operative or pre-anaesthetic sedation under the care of an anaesthetist only.  These guidelines should not be used for sedation for other procedures on Bramble ward or Caroline Thorpe Wards, nor any adult wards or emergency departments when not under the direct care of an anaesthetist – in this circumstance, please refer to relevant  Guidelines available on the Hub such as Bramble paediatric sedation protocol or adult rapid tranquilisation guidelines as appropriate for the clinical situation, or seek guidance from senior medical staff.</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Adults with very complex requirements who may need sedation or anaesthesia at home or in the hospital car park are highly unusual and require extensive MDT planning before the day of the procedure.  These patients are outside the remit of this guideline and should be referred to the adult Learning Disability team who can co-ordinate the pre-procedure discussions, meetings and planning.</li>
</ul>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">3.	DEFINITIONS</h2>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">Learning Disability</h3>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">According to the World Health Organisation ICD-10, a learning disability is a condition of arrested or incomplete development of the mind, with mild to profound impairment in cognition, language, motor and social skills.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">People with a learning disability may take more time to understand complex information and co-operate with others</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">The level of care depends upon individual factors, including both the severity and the nature of their disability.</li>
</ul>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Sedation</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Sedation is a drug-induced depression of consciousness, which is a continuum culminating in general anaesthesia.  The Academy of Medical Royal Colleges (AoMRC) and the American Society of Anaesthesiologists (ASA) define 4 levels of sedation:</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Minimal sedation (anxiolysis) – normal response to verbal stimulation</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Moderate sedation – purposeful response to verbal or tactile stimulation</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Deep sedation – purposeful response only to repeated or painful stimulation</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">General anaesthesia – no response even with painful stimulus</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">As patients pass along the continuum from minimal to deeper levels of sedation, increasing depression of normal physiological responses occurs.</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">4.	Sedative Pre Medication</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">4.1 	Aims of Pre Medication</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The aims of premedication are to reduce patient and carer anxiety and improve overall experience.  It may provide amnesia and also could reduce behavioural changes post operatively.   The anticipated effects of the sedation should be explained to the parents/ carers (and child if appropriate).  If the patient has received pre-medication previously, it is useful to determine the medication used, route, effectiveness and any adverse events that may have occurred.  The advantages must outweigh the potential disadvantages (such as worsening anxiety associated with the administration of the medication or paradoxical reactions that can be seen).</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The medication and route of administration chosen will depend on the particular circumstances on the day, the patient’s previous experiences with sedative pre-medication and co-operation and tolerability of each possible route.  The fasting status should be confirmed before any sedative medication is given.</p>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">Patients who may benefit from sedative premedication:</h3>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">Children or adults with special educational or behavioural needs</h3>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">Children having major surgery</h3>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">Children having repeated procedures</h3>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">Children who have had a previous bad experience of the hospital environment</h3>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Children or adults with anxiety</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Children with past history of stormy anaesthetic induction or emergence</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">4.3	Contra-indications to sedative pre-medication include:</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Difficult airway</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Increased aspiration risk</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Severe obstructive sleep apnoea</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Raised intracranial pressure</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Severe hepatic or renal impairment</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Previous allergic or behavioural reaction to the premedication planned</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">New or unexplained reduced saturations on room air</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Severe respiratory disease e.g. COPD requiring long term oxygen therapy</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Acute systemic illness e.g. severe sepsis</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">In these situations, if a sedative premedication is warranted, please discuss with a paediatric anaesthetist or on call anaesthetic consultant in the first instance.  The decision to give sedative pre-medication will need to be made on an individualised basis.</p>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">4.4 Roles and Responsibilities</h3>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">4.4.1 The Anaesthetist is responsible for:</h3>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Choice of sedative premedication</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Ensuring that sedative premedication is prescribed correctly on the appropriate prescription chart, and where possible in line with the current guideline</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Ensuring that the patient is in a safe environment</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Ensuring parents or carers are aware of the effects of any sedation administered</li>
</ul>
<h3 style="font-size:13px;color:#2C3E50;margin:14px 0 6px;font-weight:700">4.4.2	The designated nurse is responsible for:</h3>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Checking the prescription and preparing the sedative premedication</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Ensuring that the premedication is safely and effectively administered</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Communicating directly with the prescribing Anaesthetist if there are any problems with the prescription or administration of the drug/s</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Maintaining a safe environment for the patient once sedation is administered which will include appropriate positioning and monitoring to avoid falls and unrecognised hypoxia (see section 4.6)</li>
</ul>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">Consent</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Where sedation is to be administered, informed consent must be gained</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Where there is reason to doubt that the adult concerned has capacity to consent, a formal mental capacity assessment must be undertaken and recorded in the notes.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">If the adult is assessed as not having capacity, then a decision should be made in their best interests.  This should be the least restrictive option with reference given to the RDUH Consent Policy</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">If preoperative oral or intramuscular sedation is planned then a discussion must occur with the patient (if appropriate) and/or the parents and carers beforehand.  This discussion must cover the indication for premedication, the risks and benefits and in case of failure the plan for ongoing management of the patient.  This discussion must be documented.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">All children should be included in discussions regarding their health and treatment as much as possible given their level of comprehension.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">4.6 Choice of medication</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.1 	Choice of medication will depend on the particular circumstances at the time and includes:</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">previous experiences with premedication</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">formulation</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">pharmacology and contra-indications</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">tolerability, preferred route and their co-operation</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.2	Combinations of medications can be used in certain circumstances (e.g. previous failure of a single agent alone) such as oral midazolam and clonidine together.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.3	In some patients with extremely challenging behaviour, up to three different medications may be required under the direction of an anaesthetist.  (See recommendations for 2nd, 3rd and 4th line options in these instances).</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.4	In some children, the recommended doses per kilogram and maximum doses can be exceeded (above that in Appendix 1 and in the BNF</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">This is the responsibility of the prescribing anaesthetist and will be based on experienced clinical judgement.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Most commonly this may be necessary with buccal midazolam as the doses in the BNF for ‘conscious sedation’ may be lower than those required for clinical effect ahead of anaesthesia.  There is considerable evidence of safety of the 300mcg/kg dose as an anaesthetic pre-medication and it is recommended in the anaesthetic literature.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">This will be prescribed and requested by the consultant anaesthetist, clearly documented and communicated with the nursing team involved.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.5 	Pathway for choosing sedative pre-medication (see Appendix 1 for table giving dosing information)</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.6 	If combinations of medications are required (i.e. 2nd, 3rd or 4th line), consideration should be given to an anaesthetic trainee, practitioner or consultant remaining with the child continuously unless there is previous experience of this combination of medications being used safely in that patient.  if the child is in a location distant to theatres e.g. Caroline Thorpe or Bramble ward</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.7	Either clonidine OR dexmedetomidine should be given NOT both</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.8	The oral preparations may be added to a small volume of flavoured squash to help with any unpleasant taste i.e. dilute with an equal volume of squash.  Medications given orally can be mixed in the same drink e.g. midazolam plus clonidine/ dexmedetomidine, midazolam plus ketamine</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.9	If intramuscular ketamine is required, it should be discussed with parents/ carers and staff in advance.  It requires 3-5 minutes to work and will need sufficient staff, appropriate monitoring and equipment and the ability to transfer the patient up to theatre rapidly.  See Appendix 4.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.10	If the refuses, spits out or vomits the medication, please contact the prescribing Anaesthetist as soon as possible.  Do not transfer the up to theatre without discussing with the anaesthetist first.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">4.6.11  Care should be taken when prescribing in the overweight child. The SOBA guideline ‘Anaesthesia for children living with obesity’ gives guidance on dose adjustments based on BMI centiles for pre-medication</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">4.7 After administration</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">The  should remain on the ward under the direct supervision of a responsible adult such as a parent or guardian.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">When the become drowsy, they should lie in bed or on a trolley.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">If they fall asleep, oxygen saturations should be continuously monitored using pulse oximetry.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Oxygen should not routinely be applied.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">If pre-medication is inadequate, additional medication may be required, at the discretion of the prescribing anaesthetist.</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 1</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Sedative Premedication Dosing in Paediatric Patients</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Notes</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The 100 microgram Clonidine tablets can be crushed and dispersed in water. This can be considered to minimise the volume of liquid.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Dexmedetomidine is shorter acting than clonidine, has little if any respiratory depression, is easy to administer intranasally and is not as irritant as intranasal midazolam.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Oral and buccal midazolam can be increased above the recommended maximum dose but this is the sole responsibility of the Anaesthetist concerned.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Ketamine can be mixed and given with midazolam at the dose described above.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Dexmedetomidine can be mixed and given with midazolam at the doses described above.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Ketamine is a good analgesic but is hallucinogenic and patients should be recovered in a relatively quiet and non-stimulating environment.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">If asked to prescribe a premedication in order to facilitate attendance for surgery. This is not a usual process and should undergo an MDT discussion prior to consideration. Alternative strategies should be sought, such as desensitisation.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 2</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Sedative Premedication Dosing in Adult Patients</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Notes</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">For adult patients who require anxiolysis before surgery, clear explanation and calm dialogue will often suffice to alleviate their fears</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">In those whom pre-medication is indicated for anxiety, benzodiazepines remain the mainstay.  The difference between these drugs is marginal.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Taking into consideration speed of onset, duration of action, side-effects and quality of anxiolysis, the most appropriate sedative premed is:</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Lormetazapam: 1-2 mg (1mg in elderly or &lt;50kg) or Lorazepam may be used: 0.5-1mg</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">(Note that the onset of action of lorazepam is longer – 90mins vs 20 mins for lormetazapam, and has a longer duration of action). See supporting information below.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">In patients with more severe agitation or those with learning difficulties or special needs, lorazepam/ lormetazepam may be insufficient, and po/ buccal midazolam may be necessary. There have been isolated cases of significant respiratory depression from using buccal midazolam in adult cases on Knapp ward.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">If midazolam is required, then an anaesthetist must be available to attend to the patient.</p>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">In difficult cases, pre-operative planning for the use of midazolam and/or other agents will have been made.  The anaesthetist should be present on the ward until transfer to theatre for these cases.</li>
</ul>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">SUPPORTING EVIDENCE</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Lormetazepam undergoes hepatic metabolism with nearly constant kinetics even if repeatedly administered.  It is safe in patients with renal impairment but used with caution in those with hepatic impairment. Lormetazepam has improved ‘controllability’ compared to midazolam. This may lead to less frequent agitation and over-sedation.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Lormetazepam has some advantages over diazepam with a greater anxiolytic effect and less hangover/ side effects.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Lorazepam has a significantly longer onset 40 mins versus 10 mins for lormetazepam although the anxiolytic effect may be less effective with lormetazepam.</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">Appendix 3: Sedative Premedication Flow Chart</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Appendix 4</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6;font-weight:700">Ketamine Intramuscular Injection</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Ketamine may be administered by intramuscular injection to patients in whom administration of oral premedication has failed.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Intramuscular ketamine has a quicker onset of action (seconds to minutes).</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The administration of intramuscular ketamine must be discussed with the child/parent/carer and this discussion should be documented.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The discussion should include alternative courses of action, a plan for administration, and the immediate effects of ketamine.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Prepare the “Ketamine intramuscular injection” to a dose of 5mg/kg in a 5ml syringe</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The parents/carers should hug or distract the child, ideally seated or lying down and consideration should be given to the use of the “Sensory Unit” and play specialists.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Ketamine can be effectively administered in one of the side rooms on the day surgery unit or in the anaesthetic room.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Keep the patients shoulder (deltoid), thigh (vastus lateralis) or buttock (ventrogluteal) exposed if possible.</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">Appendix 5:</h2>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">Mucosal Atomizer Device (MAD) and intranasal administration of dexmedetomidine</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Use the MAD device to administer 2-3 micrograms/kg of Dexmedetomidine neat (100 micrograms/ml)</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Intranasal dexmedetomidine may be challenging to deliver to patients who are already anxious and unable to tolerate oral medications.  The administration of intranasal dexmedetomidine must be discussed beforehand with the child/parents/carers and team and this discussion must be documented. The discussion should include alternative courses of action and a plan for administration.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Use of concentrated medication solutions in a small volume (0.2– 0.3 mL per nostril) is considered ideal, with volumes in excess of 1 mL per nostril not being reliably absorbed as a result of mucosal surface saturation and run-off from the nasal cavity</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Dexmedetomidine is 100mcg/ml solution</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">For doses from 10 - 79 micrograms: dilute required dose to a final volume of 0.8mL with sodium chloride 0.9% and give 0.4mL into each nostril.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">For doses from 80-200 micrograms use without further dilution, dividing the total dose between the two nostrils.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">A 2ml syringe is generally the right size to use, and make sure that the sponge is gently but firmly nestled in the nostril to avoid shooting the device across the room</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The internal volume of the atomiser creates a “dead space” which has the potential to retain a proportion of the drug intended for administration and cause incomplete delivery of the intended drug dose. The exact volume of the dead space will depend on both the specific MAD and syringe type used, but is typically in the region of 0.1-0.16mL. Details of the volume for a specific MAD can usually be found in the package leaflet provided with the product.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">One method for ensuring that the dead space does not lead to delivery of a reduced dose is to use an air bubble introduced into the syringe before administration.  The syringe should be manipulated so the drug solution is at the top of the syringe and the air bubble sits between the syringe plunger and the drug solution. During administration, the air bubble flushes the drug solution through the MAD, meaning that air is retained within the dead space rather than drug solution.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Drug solution		Air bubble</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">A short sharp expulsion of drug from the syringe ensures that the liquid is optimally atomized.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">The nostrils should also be examined for either excess mucus or blood as this will hinder drug absorption; nostrils may also be suctioned prior to administration</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">5.	MONITORING COMPLIANCE WITH THIS GUIDELINE</h2>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">Standards/Key Performance Indicators</h2>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Adequate sedation and compliance for anaesthesia in children or adults with learning disabilities</li>
</ul>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Improved pre-operative sedation in the target groups as reported by the Anaesthetic team</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">Process for Implementation and Monitoring Compliance and Effectiveness</h2>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Guideline will be presented at anaesthetic governance and distributed to relevant parties.</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Guidelines will be available on the intranet</p>
<p style="font-size:12px;color:#2C3E50;margin:6px 0;line-height:1.6">Feedback will be sought from relevant parties and Datixes reviewed.</p>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">ASSOCIATED CLINICAL GUIDELINES OR POLICIES/PROCEDURES</h2>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Consent for Examination or Treatment Policy. RDUH. 2021. https://royaldevonstaff.nhs.uk/download.cfm?ver=21896</li>
</ul>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">References</h2>
<ul style="margin:4px 0;padding-left:20px">
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Sedation in under 19s: using sedation for diagnostic and therapeutic procedures, [CG112] NICE guidelines 2010.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">J. Short, A. Calder Anaesthesia for children with special needs, including autistic spectrum disorder. Continuing Education in Anaesthesia, Critical Care and Pain Jan 2013.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">W. Funk, W. Jakob, T. Riedl, K.Taeger Oral preanaesthetic medication for children: double blind randomised study of a combination of midazolam and ketamine vs midazolam or ketamine alone BJA 84(3): 335-40 (2000)</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">N. Almenrader, M.Passariello, B.Coccetti et al Premedication in children: a comparison of oral midazolam and oral clonidine Pediatric Anesthesia 2007 17:1143- 1149</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Paediatric Clinical Practice Guideline, Royal Alex Hospital, Brighton, 2016.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Paediatric Formulary, 8th Edition, Evelina Children’s Hospital.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Dexmedetomidine: perioperative applications in children. Pediatric Anesthesia. 2010; 20:256-264</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Oral Dexmedetomidine Achieves Superior Effects in Mitigating Emergence Agitation and Demonstrates Comparable Sedative Effects to Oral Midazolam for Pediatric Premedication: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Jen et al. J Clin Med 2024 13 (4) 1174</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Academy of Medical Royal Colleges:  Safe sedation practice for Healthcare Procedures: An Update.  2021.  https://www.aomrc.org.uk/wp-content/uploads/2021/02/Safe_sedation_practice_for_healthcare_procedures_update_0521.pdf (accessed June 2024)</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">ASA.  Statement on Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia. Committee of Origin: Quality Management and Departmental Administration.  2019.  https://www.asahq.org/standards-and-practice-parameters/statement-on-continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedation-analgesia</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Postoperative behavioural outcomes in children: effects of sedative premedication.  Kain ZN et al.  Anaesthesiology 1999, vol 90, 758-765</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Anxiolytic premedication for children.  S Heikal and G Stuart.  BJA Education, 20 (7):220-225 (2020)</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Anaesthesia for Children Living with Obesity.  Accessed online 28/06/2024: Microsoft PowerPoint - Paediatric SOBA 1-page guide V15 (sobauk.co.uk)</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Position statement 2023-03.  Use of injection solutions to administer analgesics or sedatives via the intranasal route.  Neonatal and Paediatric Pharmacists Group, November 2023.</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Autism and Anaesthesia: A simple framework for everyday practice. BJA Education. 24 (4) 2024 p129-137</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Perioperative care of elective adult surgical patients with a learning disability Anaesthesia 2022.  King and Duffy.  Vol 77 issue 6 p674-683</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">Jakobsen CJ, Jensen JJ, Hansen W, Grabe N Oral lormetazepam in premedication. A comparison with diazepam. Anasethesia 1986 Aug 41(8):870-3</li>
<li style="font-size:12px;color:#2C3E50;margin:3px 0;line-height:1.5">MA Claeys, F Camu Efficacy of lorazepam and lormetazepam as intravenous premedicants for and surgery Acta anaesthesiologica belgica, 1986, 37(2), 113‐120 | added to CENTRAL: | 1998 Issue 1</li>
</ul>
<h2 style="font-size:15px;color:#1A5276;margin:20px 0 8px;font-weight:700">7.	PUBLICATION DETAILS</h2>
</div>
</body>
</html>